RxRescue vs LSPedia

RxRescue vs LSPedia — the honest comparison.

Pharmacy buyers comparing RxRescue to LSPedia are usually comparing two products that sit at different layers of the DSCSA stack. This page is the honest version: where each one fits, where each one is genuinely the better tool, and why most well-prepared pharmacies end up with one of each.

What LSPedia is, plainly

LSPedia's flagship dispenser product is OneScan Pharmacy Pro — an upstream DSCSA compliance platform that receives Advanced Shipping Notice (ASN) and EPCIS data from a pharmacy's wholesalers, verifies trading-partner licensure (including National Association of Boards of Pharmacy integration), runs the Verification Router Service (VRS) for product verification, provides DSCSA-compliant standard operating procedures, and offers their Investigator technology for resolving EPCIS exceptions. LSPedia positions this as the industry-leading DSCSA solution for dispensers, with a stated 150,000+ pre-established AS2 connections enabling rapid wholesaler onboarding.

That's a real product solving a real problem. The DSCSA T3 / EPCIS data interoperability burden is genuine, the trading-partner licensure verification requirement is a real legal obligation, and automating it removes a meaningful operational tax. LSPedia is one of the larger players in that space and has well-established partnerships with pharmacy management vendors (BestRx, RedSail, Pharmsource) and buying groups (MatchRX). For a pharmacy whose primary DSCSA pain is upstream data handling, LSPedia is one of the credible answers.

What RxRescue is, plainly

RxRescue is the on-shelf physical-inventory layer for pharmacies. It runs on Windows and Android, captures GS1 2D-barcode bottle data (GTIN, lot, serial, expiration) at receiving, runs a FEFO expiration dashboard with color-coded urgency, checks the openFDA recall feed daily against your actual on-hand stock, generates wholesaler return manifests in Cardinal / McKesson / AmerisourceBergen format, and produces a one-tap DSCSA audit pack (six synchronized CSV exports) when an inspector shows up. It operates offline-first, syncs across multiple devices in a single pharmacy, and is intentionally designed not to collect Protected Health Information (PHI). It is $99/month flat per pharmacy with unlimited devices and a 30-day free trial.

RxRescue is not an upstream data platform. It doesn't establish AS2 connections to wholesalers, doesn't run a Verification Router Service, and doesn't maintain a national trading-partner license database. The pharmacy's wholesaler portal handles the T3 transaction record retention for the federally required six years (Cardinal, McKesson, AmerisourceBergen all do this for free), and RxRescue handles the rest of the dispenser-side DSCSA obligations on the shelf.

Layer-by-layer comparison

The honest comparison is to ask which layer matters for which DSCSA-required workflow.

Capability LSPedia OneScan Pharmacy Pro RxRescue
Primary layerUpstream data (EPCIS / ASN / AS2)On-shelf physical inventory
Data captureElectronic from wholesalers; "no scanning required"Scanner-driven physical receiving (GS1 2D barcode)
Trading-partner license verificationYes — NABP integrationNo
Verification Router Service (VRS)YesNo
EPCIS exception resolutionYes — Investigator technologyNo
FEFO expiration dashboardNoYes — color-coded urgency
Daily FDA recall match vs. on-hand stockNoYes — openFDA feed checked daily
Wholesaler return manifestsNoYes — Cardinal / McKesson / AmerisourceBergen
One-tap DSCSA audit packNoYes — six synchronized CSV exports
Offline-first / restricted environmentsNo — cloud-onlyYes — scan-queue, sync when network returns
Onboarding~30-day partner-network enrollmentSelf-serve, ~5-min install, scan same shift
No-PHI / No-BAA procurement postureConfirm directly with vendorYes — designed not to collect PHI
Pricing$129/mo list (late-2024); partner discounts$99/mo flat, unlimited devices, no setup, 30-day trial

As with any upstream-vs-on-shelf comparison in this category, the rows aren't a scoreboard — they're a map of which layer each tool covers. LSPedia owns the upstream data rows; RxRescue owns the on-shelf execution rows; a complete DSCSA program covers both.

Upstream data: EPCIS, ASN, AS2, trading-partner verification

LSPedia is built for this; RxRescue is not. If the pharmacy doesn't have a managed compliance service and needs continuous automated trading-partner license verification, LSPedia (or a similar platform) is the right tool. The wholesaler portals handle T3 storage for free in most cases, but they don't provide active license-monitoring or VRS — that's where an upstream platform earns its keep.

On-shelf physical inventory: scanning, FEFO, recall match, audit pack

RxRescue is built for this; LSPedia's automation-first model deliberately minimizes scanning. LSPedia's "no scanning required" workflow relies on the electronic data accurately representing what physically arrived in the tote. In practice, electronic data and physical product diverge — in FDA-supported DSCSA pilot studies, participants reported discrepancy rates in incoming shipments as high as roughly a quarter of shipments. RxRescue captures the bottle that actually arrived — which is also the bottle that has to be on the shelf, in the count, in the FEFO list, and in the recall match.

Operational reach: offline operation, restricted environments

RxRescue is built for environments where the network drops, sometimes for hours. Cloud-only platforms like LSPedia OneScan stop working when the connectivity does. In a correctional med room, a basement clinic, or a county-IT-locked-down facility, that's not a feature; that's a deal-breaker. For pharmacies in those settings, the offline-first architecture is genuinely the differentiator.

Procurement and IT-security review

RxRescue is designed not to collect PHI, so no Business Associate Agreement (BAA) is required. Most facilities clear RxRescue through a short security-review path rather than the longer BAA-required vendor track. LSPedia's posture on PHI/BAA is governed by its own architecture (EPCIS data is product data, not patient data, so similar considerations may apply — verify directly with their team). The procurement-flow difference matters most for buying-group members and IT-cautious community pharmacies.

Onboarding and time to value

LSPedia onboards through a partner-network enrollment process — their materials cite a ~30-day onboarding using pre-established AS2 connections. RxRescue is self-serve: install on Windows or Android in five minutes, get the setup code by email from Stripe Checkout, scan the first bottle the same shift. For a pharmacy that wants to evaluate quickly without a sales conversation, that's a different evaluation experience.

Pricing

LSPedia's public list price as of late 2024 is $129/month for new OneScan Pharmacy Pro accounts. Partner programs (MatchRX, BestRx, RedSail, Pharmsource) offer reduced pricing for member pharmacies. RxRescue is $99/month flat per pharmacy with unlimited devices, no setup fee, and a 30-day free trial. The right reading of the price difference is not "which is cheaper" — the two cover different layers and a serious DSCSA program often needs both.

When LSPedia is the right call

If the pharmacy's primary DSCSA need is upstream data handling — receiving EPCIS data automatically from a long list of suppliers, continuous trading-partner license monitoring, VRS verification, and a managed-service relationship that handles the data-interoperability complexity — LSPedia is one of the strongest options in the category. The partner-network integrations with BestRx, RedSail, Pharmsource, and MatchRX also make LSPedia a natural fit for pharmacies already in those ecosystems.

When RxRescue is the right call

If the pharmacy's primary DSCSA need is on-shelf execution — knowing what physically arrived, surfacing expiration and FDA recalls against actual on-hand stock, generating the audit pack an inspector asks for, running the wholesaler return-manifest workflow for short-dated inventory — RxRescue is purpose-built for that. The fit is especially strong in three patterns:

The two-layer pattern (most well-prepared pharmacies)

The honest version: most pharmacies that take DSCSA seriously end up with one upstream layer (LSPedia, Advasur, or similar) and one on-shelf layer (RxRescue). They answer different audit questions. The upstream layer answers "show me the T3 records and the trading-partner licenses for that bottle." The on-shelf layer answers "show me what's actually on the shelf right now, what's expiring, what's recalled, and the audit pack."

Asking which one to pick is the wrong question. The right question is which layer the pharmacy currently has weakest coverage on. For pharmacies that already have LSPedia (or a similar upstream service), adding RxRescue closes the on-shelf gap that upstream services don't cover. For pharmacies that have neither, the wholesaler portal handles upstream T3 storage for free in most cases, and RxRescue handles the rest of the dispenser-side obligations — a sensible single-product starting point that scales.

Frequently asked questions

Is RxRescue a direct alternative to LSPedia?

For one specific layer, yes — the dispenser-side DSCSA records and audit-pack generation. For the upstream EPCIS / ASN / VRS / trading-partner-verification layer, no — LSPedia is built for that and RxRescue is not.

When is RxRescue the better fit than LSPedia?

Offline environments, No-PHI/No-BAA procurement, and pharmacies that want to evaluate quickly without a sales process.

Can a pharmacy use both LSPedia and RxRescue?

Yes. The two operate at independent layers and require no integration.

How does pricing compare?

LSPedia: $129/month list for new accounts (late-2024 public pricing), partner-program discounts available. RxRescue: $99/month flat per pharmacy, no setup fee, 30-day self-serve trial.

Where to go next

Information about LSPedia on this page is drawn from LSPedia's public product materials and is current as of 2026. Verify pricing and feature details directly with LSPedia before quoting. RxRescue is not affiliated with LSPedia, Inc.